Introduction {#S1}
============

Transient ischemic attack (TIA) is a brief neurological event caused by temporary ischemia without acute infarction ([@B1]). Clinical symptoms include motor and speech impairments ([@B2]). These focal neurological symptoms are assumed to be resolved within 24 hrs. leaving no permanent damage to the central nervous system ([@B3]). Despite this, the risk for stroke increases up to 20% following a TIA ([@B4]). Nevertheless, the association between the presence of motor impairments during a TIA and a subsequent stroke is not well understood.

Interestingly, clinicians intuitively believe that motor impairments during a TIA predispose individuals to a greater risk for stroke. However, this clinical proposition lacks empirical validation. To-date, no study has quantified the influence of motor impairments during a TIA on the odds of a subsequent stroke. Therefore, the purpose of the current meta-analysis is to examine whether the odds of a subsequent stroke are greater in individuals who experience motor impairments during a TIA compared with those who do not experience motor impairments.

Typical motor impairments associated with TIA include unilateral motor weakness, paralysis of limbs, gait disturbance, and loss of coordination ([@B2]). However, clinical reports on motor impairments during a TIA have focused primarily on decreased muscle strength or motor weakness. A primary reason for the clinical focus on motor weakness is that weakness is easily examined in clinics as reduced muscle force during manual motor testing ([@B5]). Further, the pathophysiological rationale for assessing motor weakness is that it reflects upper motor neuron dysfunction associated with TIA and is a common accompaniment of other motor impairments ([@B6], [@B7]). Therefore, in the current meta-analysis, we use motor weakness as the primary measure of motor impairment during a TIA.

Several prognostic scores have been used to predict the risk of stroke after TIA ([@B8]) These scores are based on clinical characteristics of the patient such as age, blood pressure, clinical symptoms of motor weakness or speech impairment, duration of symptom, and diabetes. More recently, diagnostic neuroimaging has increased the predictive power of the clinical scores ([@B9]). Undoubtedly, the cumulative scores based on clinical and imaging characteristics provide useful information for TIA management. However, the unique contribution of motor impairments to increased risk for stroke has not been determined.

We use rigorous meta-analytic techniques to determine the extent to which the presence of motor impairments influences the likelihood of a subsequent stroke. Data from 24 studies with 15,129 participants from North America, Australia, Asia, and Europe are extracted and submitted to a meta-analysis. The current meta-analysis aims to precisely quantify the influence of motor impairments during a TIA on the risk for a subsequent stroke and inform clinicians, policy makers, and public educators on the importance of identifying and recognizing motor impairments in TIA.

Materials and Methods {#S2}
=====================

Study Inclusion and Exclusion Criteria {#S2-1}
--------------------------------------

The PRISMA guidelines directed the search and reporting of this meta-analysis. We conducted an exhaustive search for TIA studies using four computerized databases: (a) MEDLINE, (b) ISI's Web of Knowledge, (c) Cochrane Database of Systematic Reviews, and (d) PsycINFO from July 1989 to December 2016. Fourteen key words and phrases dictated the search: TIA, stroke recurrence, motor deficit, weakness, hemiparesis, limb function, unilateral weakness, coordination, impairments, walking, gait disturbance, ataxia, dysarthria, and physical limitations. Additional search strategy involved manual searches to examine the reference lists of retrieved articles. Our initial search identified 126 records that discussed motor impairments in TIA and a subsequent stroke. We excluded the systematic reviews and studies that used the same population as another included study. Ninety-three unique records remained for additional screening. Figure [1](#F1){ref-type="fig"} describes the literature search and screening process.

![Study selection. Literature search and screening process.](fneur-08-00243-g001){#F1}

The inclusion/exclusion criteria were the following: (1) the study reported an odds ratio relating motor impairments to the chances of a subsequent stroke, or the number of individuals with and without motor impairments who experienced a subsequent stroke. Thirty-two of the original 93 studies met this criterion. (2) If studies evaluated multiple populations, such as minor stroke and TIA, then data for TIA population was reported separately. Three studies did not meet this criterion ([@B10]--[@B12]). (3) The recurrent ischemic event was required to be a stroke, not a recurrent TIA. Five papers failed this criterion ([@B13]--[@B17]). Twenty-four studies remained and were submitted to the meta-analysis ([@B18]--[@B41]). Two authors (Neha Lodha and Jane Harrell) independently coded and extracted data. A divergent evaluation was resolved in consultation with a third investigator (Evangelos A. Christou). All three investigators confirmed data extractions. All authors participated in the interpretation of the meta-analytic results. Table [1](#T1){ref-type="table"} describes the design and setting of the studies included in the meta-analysis.

###### 

Design and setting of studies included in the meta-analysis.

  Study name                      Study period   Country             Clinical setting                   Ascertainment method                                     Transient ischemic attack (TIA) diagnosed by   Follow-up
  ------------------------------- -------------- ------------------- ---------------------------------- -------------------------------------------------------- ---------------------------------------------- ---------------------------
  Al-Khaled and Eggers ([@B18])   2007--2010     Germany             Multiple EDs                       Prospective (consecutive referrals to stroke registry)   Neurologist, internist                         Questionnaire
  Ay et al. ([@B19])              2000--2006     USA                 Single ED                          Retrospective (review of inpatient/outpatient reports)   Neurologist                                    Medical records
  Bray et al. ([@B20])            2004           Australia           Single ED                          Retrospective (admissions to ED)                         ED physician                                   Medical records and phone
  Chandratheva et al. ([@B21])    2002--2007     England             Multiple EDs and clinics           Prospective (multiple search methods)                    Neurologist                                    In person
  Chen et al. ([@B22])            2006--2009     China               Multiple hospitals                 Prospective (admissions to hospital)                     Neurologist                                    In person
  Coutts et al. ([@B23])          Undetermined   Canada              Hospital stroke center             Prospective (referral to stroke team)                    Stroke neurologist                             In person
  Dai et al. ([@B24])             2009--2013     China               University hospital                Prospective (stroke registry)                            Neurologist                                    In person or phone
  Fujinami et al. ([@B25])        2008--2009     Japan               Multiple stroke hospitals          Retrospective (review of medical records)                Attending physician                            Medical records
  Gon et al. ([@B26])             2006--2013     Japan               Hospital stroke unit               Retrospective (review of medical records)                Not listed                                     Not listed
  Hayashi et al. ([@B27])         2007--2010     Japan               Single ED                          Retrospective (review of medical records)                Neurologist                                    Medical records
  Johnston et al. ([@B28])        1997--1998     USA                 Multiple EDs                       Retrospective (review of medical records)                ED physician                                   Medical records
  Jove et al. ([@B29])            2008--2012     Spain               Single ED                          Prospective (admissions to ED)                           Neurologist                                    In person
  Li et al. ([@B30])              2010--2011     China               Single ED                          Prospective (admissions to ED)                           Neurologist                                    In person
  Lim et al. ([@B31])             2010--2012     Korea               Multiple EDs                       Prospective (admissions to ED, Korean TIA Registry)      Neurologist                                    In person or phone
  Nakajima et al. ([@B32])        2002--2004     Japan               Specialist cardiovascular center   Prospective (admissions to cardiovascular center)        Neurologist                                    Medical records or Phone
  Ohara et al. ([@B33])           2008--2013     Japan               Hospital stroke center             Retrospective (review of stroke database records)        Stroke neurologist                             In person
  Ois et al. ([@B34])             2004--2007     Spain               Single ED                          Prospective (admissions to ED)                           Neurologist                                    In person or Phone
  Ong et al. ([@B35])             2005--2006     Singapore           Single ED                          Retrospective (ED database and medical records)          ED physician                                   Medical records
  Perry et al. ([@B36])           2006--2011     Canada              Multiple EDs                       Prospective (admissions to ED)                           ED, neurologists, residents                    Phone
  Purroy et al. ([@B37])          2002--2005     Spain               Single ED                          Prospective (admissions to ED)                           Neurologist                                    In person
  Purroy et al. ([@B38])          2006--2009     Spain               Single ED                          Prospective (admissions to ED)                           Neurologist                                    In person
  Purroy et al. ([@B39])          2008--2009     Spain               Multiple stroke centers            Prospective (admissions to stroke center)                Stroke neurologist                             In person
  Tsivgoulis et al. ([@B40])      2008--2009     Greece, Singapore   Multiple neurology departments     Prospective (admissions to ED)                           Neurologist                                    In person
  Zhao et al. ([@B41])            2008--2011     China               Neurology department               Prospective (admissions to neurology)                    Neurologist                                    Phone

*ED, Emergency Department*.

Clinical Symptoms/Outcome Measures {#S2-2}
----------------------------------

We identified nine outcome measures related to motor impairment (a) motor lacunar symptom, (b) motor deficits, (c) motor weakness, (d) weakness, (e) unilateral weakness, (f) unilateral motor weakness, (g) focal weakness, (h) limb weakness, and (i) hemiparesis. The study authors defined these outcomes as motor weakness. We extracted data on all available motor outcome measures from each study. Only a few studies reported more than one outcomes ([@B18], [@B27], [@B28], [@B32], [@B36], [@B38], [@B40]). To prevent data biasing, we followed standard recommendations and selected one outcome measure per study that best represented motor weakness. Table [2](#T2){ref-type="table"} lists these outcome measures and other study characteristics.

###### 

Characteristics of studies included in the meta-analysis.

  Study name                      Age                  Sex                    Sample size   Clinical symptom/outcome measure   Symptom to evaluation   Clinical evaluation   Neuroimaging evaluation   Neuroimaging findings                                      Recurrence time
  ------------------------------- -------------------- ---------------------- ------------- ---------------------------------- ----------------------- --------------------- ------------------------- ---------------------------------------------------------- ------------------------
  Al-Khaled and Eggers ([@B18])   70.6 ± 12.8          M = 1,122, F = 1,078   2,200         Unilateral Motor Weakness          2 days                  ABCD^2^ score         MRI with DWI              --                                                         During hospitalization
  Ay et al. ([@B19])              67.7 ± 14.7          M = 231, F = 246       477           Focal Weakness                     1 day                   ABCD^2^ score         MRI with DWI              DWI +ve = 136; DWI −ve = 318                               7 days
  Bray et al. ([@B20])            73 ± 14.5            M = 49, F = 49         98            Unilateral Weakness                2 days                  ABCD score            --                        --                                                         90 days
  Chandratheva et al. ([@B21])    72.5 ± 12.7          M = 219, F = 281       488           Unilateral Weakness                1 day                   ABCD^2^ score         CT or MRI                 --                                                         1 day
  Chen et al. ([@B22])            --                   --                     199           Limb Weakness                      --                      --                    CT or MRI                 --                                                         90 days
  Coutts et al. ([@B23])          Median 69 (27--99)   M = 293, F = 206       499           Motor Weakness                     2 days                  ABCD^2^ score         CT or MRI with DWI        CT +ve = 171; CT −ve = 328; DWI +ve = 243; DWI −ve = 256   7 days
  Dai et al. ([@B24])             62 ± 12.5            M = 486, F = 176       658           Motor Weakness                     3 days                  ABCD score            MRI with DWI              DWI +ve = 236; DWI −ve = 422                               90 days
  Fujinami et al. ([@B25])        69 ± 13              M = 292, F = 172       464           Hemiparesis                        7 days                  ABCD^2^ score         MRI with DWI              DWI +ve = 96; DWI −ve = 368                                During hospitalization
  Gon et al. ([@B26])             64 ± 15              M = 88 F = 51          139           Motor Weakness                     7 days                  ABCD^2^ score         MRI with DWI              DWI +ve = 53; DWI −ve = 86                                 14 days
  Hayashi et al. ([@B27])         66.6 ± 11.0          M = 44, F = 30         74            Hemiparesis                        --                      ABCD^2^ score         MRI with DWI              --                                                         2 years
  Johnston et al. ([@B28])        Mean 72              M = 808, F = 899       1,707         Weakness                           --                      --                    --                        --                                                         90 days
  Jove et al. ([@B29])            71.7 ± 10.8          --                     293           Weakness                           1 day                   ABCD^2^ score         MRI with DWI                                                                         90 days
  Li et al. ([@B30])              67.5 ± 11.1          M = 70, F = 36         106           Motor Deficits                     --                      ABCD^2^ score         MRI with DWI                                                                         7 days
  Lim et al. ([@B31])             64.4 ± 11.8          M = 291, F = 209       500           Motor Weakness                     2 days                  ABCD^2^ score         MRI with DWI              DWI +ve = 140; DWI −ve = 335                               90 days
  Nakajima et al. ([@B32])        65 ± 12              M = 81, F = 32         113           Hemiparesis                        7 days                  ABCD^2^ score         CT, MRI with DWI          DWI +ve = 39; DWI −ve = 74                                 90 days
  Ohara et al. ([@B33])           −                    M = 263, F = 147       410           Motor Lacunar Symptom              2 days                  ABCD^2^ score         MRI with DWI              DWI +ve = 119; DWI −ve = 291                               7 days
  Ois et al. ([@B34])             −                    −                      221           Weakness                           −                       ABCD score            CT                                                                                   90 days
  Ong et al. ([@B35])             61 ± 13.2            M = 293, F = 177       470           Unilateral Weakness                −                       ABCD^2^ score         CT or MRI                 −                                                          90 days
  Perry et al. ([@B36])           68.0 ± 14.4          M = 1,930 F = 1,976    3,906         Weakness                           \<7 days                −                     CT                        CT +ve = 1,101                                             7 days
  Purroy et al. ([@B37])          70.8 ± 12            M = 230, F = 158       388           Weakness                           1 day                   ABCD^2^ score         CT                        --                                                         90 days
  Purroy et al. ([@B38])          69.3 ± 11.8          M = 156, F = 98        254           Motor Weakness                     7 days                  ABCD^2^ score         CT, MRI with DWI          DWI +ve = 117 DWI −ve = 137                                90 days
  Purroy et al. ([@B39])          68.6 ± 13.1          M = 674, F = 463       1,137         Motor Weakness                     2 days                  ABCD^2^ score         CT, MRI with DWI          DWI +ve = 194 DWI −ve = 269                                90 days
  Tsivgoulis et al. ([@B40])      60 ± 14              M = 82, F = 66         148           Unilateral Weakness                --                      ABCD^2^ score         CT or MRI                                                                            90 days
  Zhao et al. ([@B41])            --                   M = 119, F = 61        180           Weakness                           --                      --                    --                        --                                                         90 days

*M, males; F, females; ABCD/ABCD^2^, Stroke Risk Score; MRI, magnetic resonance imaging; DWI, diffusion weighted imaging; CT, computerized tomography; Recurrence time is time from TIA symptom onset to stroke*.

Data Synthesis and Analysis {#S2-3}
---------------------------

We evaluated the quality of the studies included in the meta-analysis by the Downs and Black method ([@B42]). The Comprehensive Meta-Analysis Program was used to synthesize and analyze the data extracted from the TIA studies. This procedure involved entering the odds ratios, lower and upper limits, and confidence levels relating motor weakness to subsequent stroke from each study and then determining an overall odds ratio (Figure [2](#F2){ref-type="fig"}). For those studies that did not report an odds ratio ([@B18]--[@B21], [@B23], [@B24], [@B26], [@B27], [@B29]--[@B31], [@B36]--[@B41]), we computed the odd ratios as OR = (*A*/*B*)/(*C*/*D*). Here, *A* is the number of individuals with weakness and a recurrent stroke, *B* is the number of individuals with weakness without a recurrent stroke, *C* is the number of individuals without weakness with a recurrent stroke, and *D* is the number of individuals without weakness and without a recurrent stroke. We conducted sensitivity analysis to determine the extent to which the odds ratio was influenced by a particular study.

![Forest plot derived from a random effects model. Each tick mark and line represents an individual odds ratio with a 95% confidence interval. The diamond shape at the bottom of the forest plot is the overall odds ratio (2.11) for all 24 studies.](fneur-08-00243-g002){#F2}

Measuring Heterogeneity and Publication Bias {#S2-4}
--------------------------------------------

*I*^2^ was computed to determine the degree of variability across studies ([@B43]). We examined publication bias using (a) funnel plot asymmetry, (b) Duval and Tweedie's trim and fill procedure that creates a funnel plot with imputed values inserted as close approximations to a completely unbiased distribution, and (c) fail-safe *N* analysis that uses the probability value of the cumulative odds ratio to determine the number of studies required to render the odds ratio insignificant.

Results {#S3}
=======

Characteristics of the Included Studies {#S3-1}
---------------------------------------

Twenty-four studies with 15,129 participants qualified for inclusion in the meta-analysis. Figure [1](#F1){ref-type="fig"} shows the step-by-step procedure of identifying studies that satisfied the criteria for inclusion in this meta-analysis. The studies were conducted between 1997 and 2013, in North America (*N* = 4, participants = 6,589), Australia (*N* = 1, participants = 98), Asia (*N* = 11, participants = 3,313), and Europe (*N* = 8, participants = 5,129). One study was conducted in two locations ([@B40]). TIA was diagnosed by a neurologist in the majority of the studies (*N* = 19). The duration between symptom onset to clinical evaluation ranged from 1 to 7 days. The clinical evaluation of motor impairment included ABCD or ABCD^2^ score (*N* = 20). The neuroimaging evaluations included magnetic resonance imaging (MRI; *N* = 18). The recurrence time from the onset of TIA symptom to occurrence of stroke varied from 1 day up to 2 years. Table [3](#T3){ref-type="table"} reports the study quality. All studies had a minimum quality score of 11 out of 17.

###### 

Quality scores using Downs and Black scale: checklist for measuring study quality.

  Study name                      1   2   3   5   6   7   9   10   11   12   13   16   18   20   25   26   Quality score
  ------------------------------- --- --- --- --- --- --- --- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---------------
  Al-Khaled and Eggers ([@B18])   1   1   1   0   1   1   0   1    1    0    1    1    1    1    0    0    11
  Ay et al. ([@B19])              1   1   1   0   1   1   1   1    1    1    1    1    1    1    0    1    14
  Bray et al. ([@B20])            1   1   1   1   1   1   1   0    1    1    1    1    1    1    1    1    15
  Chandratheva et al. ([@B21])    1   1   1   2   1   1   0   1    1    0    1    1    1    1    1    0    14
  Chen et al. ([@B22])            1   1   1   1   1   1   1   0    1    1    1    1    1    1    1    1    15
  Coutts et al. ([@B23])          1   1   1   2   1   1   1   1    0    0    1    1    1    1    1    1    15
  Dai et al. ([@B24])             1   1   1   1   1   1   1   1    1    1    1    1    1    1    0    1    15
  Fujinami et al. ([@B25])        1   1   1   2   1   1   1   1    1    1    1    1    1    1    0    1    16
  Gon et al. ([@B26])             1   1   1   1   1   1   0   0    1    0    1    1    1    1    0    0    11
  Hayashi et al. ([@B27])         1   1   1   1   1   1   0   1    0    0    1    1    1    1    0    0    11
  Johnston et al. ([@B28])        1   1   1   0   1   1   1   1    1    1    1    1    1    1    0    1    14
  Jove et al. ([@B29])            1   1   1   2   1   1   0   1    1    0    1    1    1    1    1    0    14
  Li et al. ([@B30])              1   1   1   0   1   1   1   1    1    1    1    1    1    1    0    1    14
  Lim et al. ([@B31])             1   1   1   2   1   1   1   1    1    1    1    1    1    1    0    1    16
  Nakajima et al. ([@B32])        1   1   1   1   1   1   1   1    1    1    1    1    1    1    1    1    16
  Ohara et al. ([@B33])           1   1   1   1   1   1   1   1    1    1    1    1    1    1    1    1    16
  Ois et al. ([@B34])             1   1   1   2   1   1   0   1    1    0    1    1    1    1    1    0    14
  Ong et al. ([@B35])             1   1   1   2   1   1   0   0    1    0    1    1    1    1    0    0    12
  Perry et al. ([@B36])           1   1   1   2   1   1   0   1    1    0    1    1    1    1    1    1    15
  Purroy et al. ([@B37])          1   1   1   1   1   1   1   1    0    0    1    1    1    1    0    1    13
  Purroy et al. ([@B38])          1   1   1   1   1   1   1   1    0    0    1    1    1    1    0    1    13
  Purroy et al. ([@B39])          1   1   1   2   1   1   1   1    1    1    1    1    1    1    0    1    16
  Tsivgoulis et al. ([@B40])      1   1   1   2   1   1   1   1    1    1    1    1    1    1    1    1    17
  Zhao et al. ([@B41])            1   1   1   2   1   1   1   1    1    1    1    1    1    1    1    0    16

*Questions 4, 8, 14, 15, 17, 19, 21, 22, 23, 24, and 27 were not used because the studies included in the meta-analysis were not interventional. Questions 1, 2, 3, 5, 6, 7, 9, 10, 11, 12, 13, 16, 18, 20, 25, and 26 add to a maximum total possible score of 17*.

Motor Impairments in TIA and Subsequent Stroke {#S3-2}
----------------------------------------------

Figure [2](#F2){ref-type="fig"} shows forest plot of the odds ratio across individual studies. The odds ratio was computed using random effects model to determine the relation between the presence of motor impairments during a TIA and the chances of a subsequent stroke. The model revealed a pooled odds ratio of 2.11 (95% CI, 1.67--2.65; *p* = 0.000). Figure [2](#F2){ref-type="fig"} shows the overall odds ratio to the right of the vertical line of no effect (1.00), indicating that the odds of a subsequent stroke are doubled in individuals who experience motor impairment during a TIA. The sensitivity analysis revealed that the odds of a subsequent stroke did not alter considerably with the exclusion of individual studies. Further, when studies with highest risk of bias (quality scores \< 14) ([@B18], [@B26], [@B27], [@B35], [@B37], [@B38]) were excluded the overall odds ratio improved to 2.12 (95% CI, 1.58--2.84; *p* = 0.000).

Heterogeneity {#S3-3}
-------------

Measurements of heterogeneity revealed an *I^2^* of 45.85 (*p* = 0.008). Because of this relatively large proportion of dispersion in the TIA studies, we conducted a random effects meta-analysis. Plotting the log odds ratio as a function of standard error revealed a symmetrical funnel plot (Figure [3](#F3){ref-type="fig"}A). This symmetrical funnel plot represents an unbiased summary effect. The majority of studies congregating on the top half of the funnel indicate the large sample sizes of the studies and a more precise estimate of the odds ratio with a smaller standard error.

![**(A)** Funnel plot of the studies for the random effects model: The *x*-axis is the log odds ratio, and the *y*-axis is the standard error associated with each study. **(B)** Funnel plot with imputed studies. Open circles represent the 24 original studies whereas black circles represent imputed studies.](fneur-08-00243-g003){#F3}

Publication Bias {#S3-4}
----------------

Figure [3](#F3){ref-type="fig"}B shows the funnel plot with imputed studies using Duval and Tweedie's trim and fill technique ([@B43]). Only four studies were imputed on the left side of the plot to achieve symmetry, signifying an unbiased effect. The black diamond on the *x*-axis indicating the recalculated log odds ratio is highly similar to the original log odds ratio. The fail-safe analysis revealed that 462 null effect findings were necessary to lower the cumulative odds ratio of 2.11 to an insignificant level. Therefore, the odds ratio associating the presence of motor impairments in TIA with a recurrent stroke offers a robust finding.

Discussion {#S4}
==========

The purpose of the current meta-analysis was to examine whether the odds of a recurrent stroke are greater in TIA individuals who experience motor impairments compared with those who do not experience motor impairments. Our meta-analysis included 24 high-quality studies that examined motor impairments in TIA and a subsequent stroke in 15,129 individuals. The novel finding from this meta-analysis is that TIA individuals with motor impairments are twice as likely to experience a stroke as compared with those who have no motor impairments. Thus, motor impairments during TIA are a significantly high-risk clinical characteristic for a recurrent stroke.

Traditionally, stroke risk is determined using ABCD^2^ score in the clinical settings ([@B40]). ABCD^2^ score is a cumulative score derived from multiple TIA characteristics including motor and speech impairment ([@B44]). However, the evidence supporting ABCD^2^ score for predicting stroke risk remains inconclusive. While previous studies showed that TIA individuals with ABCD^2^ score of \>3 were at a high early risk of stroke ([@B44], [@B45]), more recent studies have questioned the reliability of the score in distinguishing the low and high risk of stroke recurrence ([@B46], [@B47]). The current meta-analysis suggests that the odds of a recurrent stroke are doubled in individuals who experience motor impairments during a TIA. These findings complement the clinical ABCD^2^ score that ascribes twice the predictive weight to unilateral motor weakness than speech impairment. Further, our findings are consistent with a recent study in urgent care setting that reported greater risk of stroke in TIA individuals with unilateral motor weakness ([@B48]). Regardless of the predictive capacity of the cumulative score, emerging evidence clearly suggests that the presence of motor impairments during a TIA in itself is a compelling determinant of the increased odds of a subsequent stroke.

One question concerns why are the odds of a subsequent stroke increased when motor impairments are present during a TIA. Clinical reports indicate that motor impairments during a TIA are often concomitant with structural brain abnormalities ([@B49]). Additionally, the presence of acute brain lesions detected as positive diffusion-weighted imaging (DWI) significantly increases the probability of a subsequent stroke following TIA ([@B50], [@B51]). Thus, one possibility is that perhaps motor impairments during a TIA increase the odds of a subsequent stroke because of an underlying ischemic lesion. Future studies are needed to clearly identify the mechanisms underlying increased stroke risk in TIA individuals with motor impairments.

Current standard of diagnostic protocol for the evaluation of motor deficits in TIA focuses primarily on the assessment of motor weakness. However, individuals with TIA experience multiple motor impairments including reduced coordination, impaired motor control, gait disturbance, dysarthria, and ataxia ([@B36], [@B52]). Thus, the clinical diagnosis of motor weakness may be inadequate for identifying residual motor deficits following TIA ([@B53], [@B54]). Clearly then, the absence of comprehensive motor examination for TIA individuals potentially understates the extent to which motor impairments are prevalent following TIA.

Further, initial symptoms are considered to be resolved shortly after the onset of TIA. Contrary to this conventional view point, recent evidence suggests that individuals experience subtle problems in functional activities of daily living up to 6 months after TIA ([@B55], [@B56]). This is corroborated by a recent report indicating that TIA individuals are more likely to consult clinicians for residual impairments than age-matched controls ([@B54]). Furthermore, about 50% of the individuals who have a TIA require rehabilitation to resolve the residual impairments that affect everyday function ([@B55], [@B57]). Thus, the supposed transient nature of initial motor impairments may not be so transient, pointing to the pressing need for a systematic evaluation and restoration of motor abilities beyond the clinically determined weakness in individuals with TIA.

Considerations and Future Directions {#S4-1}
------------------------------------

Few limitations of the meta-analysis findings require consideration. First, our findings may be modest in determining on the true impact of motor impairments on the odds of a recurrent stroke. This is because we extracted the data on most widely reported motor impairment, i.e., motor weakness, despite multiple motor symptoms associated with TIA. In addition, the relatively large variability in the time from symptom onset to evaluation at hospital admission contributes to the unrecognized diagnosis of motor impairments due to symptom recession or missed reporting by individuals who sought delayed medical attention. Further, the tissue-based definition for TIA diagnosis recommends the use of neuroimaging for distinguishing a minor stroke from a TIA. However, the majority of studies included in this meta-analysis based their diagnosis of TIA on the time-based definition. Finally, these findings do not understate the importance of careful clinical follow-up in TIA individuals without motor impairments. Rather, they point to the need for differential clinical care and rehabilitation of TIA individuals who experience motor impairments. In summary, the findings from the current meta-analysis offer strong evidence favoring significantly greater risk of a subsequent stroke in TIA individuals who experience motor impairments.

Given the findings from this meta-analysis, a comprehensive clinical evaluation of motor impairments is highly recommended. For example, examining motor output variability, accuracy, symmetry, and coordination deficits will provide more meaningful insights into the overall decline in motor ability following TIA. Our past work shows that motor control abilities are more predictive of everyday function in older adults than motor weakness ([@B58]). Thus, a comprehensive motor examination following TIA will further our understanding of the impact of motor impairments on functional tasks of daily living and improve the treatment and rehabilitation of residual motor impairments.

Conclusion {#S5}
==========

Transient ischemic attack individuals with motor impairments are at significantly greater risk for a recurrent stroke. The current evidence for motor impairments following TIA relies exclusively on the clinical reports of motor weakness. A comprehensive examination of motor impairments in TIA will enhance TIA prognosis and restoration of residual motor impairments.
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